Translations:Angiotensin II receptor blocker/17/en
Jump to navigation
Jump to search
A 2016 meta-analysis including 148,334 patients found no significant differences in cancer incidence associated with ARB use.
A 2016 meta-analysis including 148,334 patients found no significant differences in cancer incidence associated with ARB use.